Progress and Challenges in COVID-19 Antiviral Treatments

This chapter explores the progress made in antiviral treatments for COVID-19, including improved management protocols that have reduced hospitalization mortality rates. It also highlights the challenges of limited drug options, particularly the mixed efficacy of remdesivir, and discusses the Biden administration's proposed investments aimed at enhancing antiviral drug development.